Brookstone Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-14,994
| Closed | -$4.12M | – | 832 |
|
|
2023
Q2 | $4.12M | Buy |
14,994
+3,411
| +29% | +$938K | 0.08% | 221 |
|
|
2023
Q1 | $3.38M | Buy |
11,583
+2,944
| +34% | +$860K | 0.07% | 244 |
|
|
2022
Q4 | $2.41M | Buy |
8,639
+1,404
| +19% | +$392K | 0.05% | 279 |
|
|
2022
Q3 | $1.84M | Buy |
7,235
+2,242
| +45% | +$569K | 0.04% | 299 |
|
|
2022
Q2 | $1.09M | Buy |
4,993
+926
| +23% | +$203K | 0.02% | 386 |
|
|
2022
Q1 | $857K | Buy |
4,067
+1,909
| +88% | +$402K | 0.02% | 445 |
|
|
2021
Q4 | $502K | Buy |
2,158
+409
| +23% | +$95.1K | 0.01% | 524 |
|
|
2021
Q3 | $496K | Buy |
1,749
+1,073
| +159% | +$304K | 0.01% | 501 |
|
|
2021
Q2 | $238K | Buy |
+676
| New | +$238K | ﹤0.01% | 640 |
|
|
2015
Q4 | – | Sell |
-25
| Closed | -$7K | – | 230 |
|
|
2015
Q3 | $7K | Sell |
25
-17
| -40% | -$4.76K | ﹤0.01% | 1277 |
|
|
2015
Q2 | $17K | Buy |
+42
| New | +$17K | ﹤0.01% | 936 |
|